News Items
Dr. Natasha O’Brown Awarded Prestigious Damon Runyon-Rachleff Innovation Award
The Department of Cell Biology and Neuroscience is delighted to announce that Dr. Natasha O’Brown has been awarded the prestigious Damon Runyon-Rachleff Innovation Award. This highly competitive honor recognizes early-career scientists who are conducting bold and innovative research with the potential to transform cancer treatment. The award provides $400,000 in funding over two years to support high-risk, high-reward projects that tackle critical challenges in cancer research. Dr. O’Brown’s groundbreaking work focuses on leveraging zebrafish models to overcome the blood-brain barrier (BBB) and improve the treatment of glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.
This is Dr. O’Brown’s latest recognition from the Damon Runyon Cancer Research Foundation, which previously supported her postdoctoral research establishing zebrafish as a model system for studying the BBB and awarded her the Dale F. Frey Breakthrough Award to further advance this system. With the Rachleff Innovation Award, Dr. O’Brown’s research will now enter an exciting translational phase. Her lab will focus on strategies to transiently open the BBB to enhance drug delivery to glioblastoma tumors, a critical step toward overcoming a major obstacle in brain cancer treatment.
Please join us in congratulating Dr. O’Brown and her team on this remarkable achievement and in celebrating this milestone for Rutgers University!
The Department of Cell Biology and Neuroscience is delighted to announce that Dr. Natasha O’Brown has been awarded the prestigious Damon Runyon-Rachleff Innovation Award. This highly competitive honor recognizes early-career scientists who are conducting bold and innovative research with the potential to transform cancer treatment. The award provides $400,000 in funding over two years to support high-risk, high-reward projects that tackle critical challenges in cancer research. Dr. O’Brown’s groundbreaking work focuses on leveraging zebrafish models to overcome the blood-brain barrier (BBB) and improve the treatment of glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.
This is Dr. O’Brown’s latest recognition from the Damon Runyon Cancer Research Foundation, which previously supported her postdoctoral research establishing zebrafish as a model system for studying the BBB and awarded her the Dale F. Frey Breakthrough Award to further advance this system. With the Rachleff Innovation Award, Dr. O’Brown’s research will now enter an exciting translational phase. Her lab will focus on strategies to transiently open the BBB to enhance drug delivery to glioblastoma tumors, a critical step toward overcoming a major obstacle in brain cancer treatment.
Please join us in congratulating Dr. O’Brown and her team on this remarkable achievement and in celebrating this milestone for Rutgers University!